Intra-Arterial Chemotherapy with Osmotic Blood-Brain Barrier Disruption for Aggressive Oligodendroglial tumors: Results of a Phase I Study

Ítems similars

• PT-04 PRELIMINARY RESULTS OF A PHASE I/II STUDY OF INTRA-ARTERIAL CHEMOTHERAPY WITH OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS
  per: Das, Paramita, et al.
  Publicat: (2014)
• SURG-42. SAFETY OF INTRA-ARTERIAL CHEMOTHERAPY WITH OR WITHOUT OSMOTIC BLOOD BRAIN BARRIER DISRUPTION IN TREATMENT OF BRAIN TUMORS
  per: Uluc, Kutluay, et al.
  Publicat: (2020)
• Unusual Cervical Spinal Cord Toxicity Associated with Intra-arterial Carboplatin, Intra-arterial or Intravenous Etoposide Phosphate, and Intravenous Cyclophosphamide in Conjunction with Osmotic Blood Brain–Barrier Disruption in the Vertebral Artery
  per: Fortin, David, et al.
  Publicat: (1999)
• NTOX-09. RECOMMENDED PHASE II DOSE OF INTRA-ARTERIAL MELPHALAN GIVEN WITH INTRA-ARTERIAL CARBOPLATIN, OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION AND DELAYED OTOPROTECTIVE SODIUM THIOSULFATE FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS
  per: Ambady, Prakash, et al.
  Publicat: (2017)
• ACTR-23. SAFETY OF INTRA-ARTERIAL CHEMOTHERAPY WITH OSMOTIC OPENING OF THE BLOOD-BRAIN BARRIER
  per: Priest, Ryan, et al.
  Publicat: (2018)